Strategic partnerships Kinomatic is actively expanding through high-profile partnerships, including a pilot with WHOOP announced in July 2026, signaling opportunities for co-developed patient recovery insights and data-driven post-op care offerings that can be cross-sold to rehabilitation networks.

Clinical leadership Recent appointment of a Chief Medical Officer and a seed-stage financing round indicate a strengthened clinical guidance and growth strategy, suggesting a readiness to scale enterprise-grade orthopedic planning solutions to larger hospital systems and surgeon networks.

Funding momentum Seed financing of four million dollars and a notable investor (Waterline Ventures) underscore investor confidence and capital runway to expand product capabilities, sales outreach, and multi-site deployments in orthopedic practices.

Opioid-sparing value Kinomatic markets a personalized, opioid-sparing surgical approach, which aligns with current healthcare cost containment and patient safety initiatives, presenting an accessible value proposition for payers and health systems seeking alternatives to traditional joint replacement pathways.

Technology stack edge Utilizing AI-driven planning, VR templating, and HIPAA-compliant workflows positions Kinomatic to target tech-forward orthopedic centers, academic medical centers, and large ambulatory surgery networks seeking advanced surgical planning and concierge recovery solutions.